2024

Walker, H., Sullivan, M. K. , Jani, B. D. , Mark, P. B. and Gallacher, K. I. (2024) Exploration of patients’ and health care professionals’ perspectives of kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study protocol. BMJ Open, 14(10), e085843. (doi: 10.1136/bmjopen-2024-085843) (PMID:39424379)

Walker, H., Day, S., Grant, C. H. , Jones, C., Ker, R., Sullivan, M. K. , Jani, B. D. , Gallacher, K. and Mark, P. B. (2024) Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review. BMC Medicine, 22, 452. (doi: 10.1186/s12916-024-03649-9) (PMID:39394084) (PMCID:PMC11470573)

Elyan, B. M.P. , Sullivan, M. K. , Hedley, J., De La Mata, N., Webster, A. C., Venugopal, B., Jones, R. J. , Lang, N. N. , Mark, P. B. and Lees, J. S. (2024) The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. BJC Reports, 2, 57. (doi: 10.1038/s44276-024-00081-7)

Sullivan, M. K. , Lees, J. S. , Rosales, B. M., Cutting, R., Wyld, M. L., Woodward, M., Webster, A. C., Mark, P. B. and De La Mata, N. (2024) Sex and the relationship between cardiometabolic risk factors and estimated GFR Decline: a population-based cohort study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.05.007) (PMID:39053834) (In Press)

Shemilt, R. et al. (2024) Sex differences in cancer outcomes across the range of eGFR. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae059) (PMID:38460949) (Early Online Publication)

Adamson, W. E. et al. (2024) Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders. EBioMedicine, 101, 105000. (doi: 10.1016/j.ebiom.2024.105000) (PMID:38360481) (PMCID:PMC10944146)

2023

Jani, B. D. , Sullivan, M. K. , Hanlon, P. , Nicholl, B. I. , Lees, J. S. , Brown, L., MacDonald, S. , Mark, P. B. , Mair, F. S. and Sullivan, F. M. (2023) Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? British Journal of Cancer, (doi: 10.1038/s41416-023-02467-9) (PMID:37880510) (Early Online Publication)

Lees, J. S. , De La Mata, N. L., Sullivan, M. K. , Wyld, M. L., Rosales, B. M., Cutting, R., Hedley, J. A., Rutherford, E., Mark, P. B. and Webster, A. C. (2023) Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding. European Stroke Journal, 8(3), pp. 756-768. (doi: 10.1177/23969873231173282)

Shemilt, R. et al. (2023) Sex differences in the diagnosis of advanced cancer and subsequent outcome in people with chronic kidney disease: an analysis of a national population cohort. medRxiv, (doi: 10.1101/2023.08.22.23294412)

Mayne, K. J., Sullivan, M. K. and Lees, J. S. (2023) Sex and gender differences in the management of chronic kidney disease and hypertension. Journal of Human Hypertension, (doi: 10.1038/s41371-023-00843-9) (Early Online Publication)

Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)

2022

Sullivan, M. K. et al. (2022) The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Medicine, 20, 420. (doi: 10.1186/s12916-022-02628-2) (PMID:36320059) (PMCID:PMC9623942)

Lees, J. S. , Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M. K. , Ebert, N., Mark, P. B. and Shlipak, M. G. (2022) Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Network Open, 5(10), e2238300. (doi: 10.1001/jamanetworkopen.2022.38300) (PMID:36282503) (PMCID:PMC9597396)

Lees, J. , Rutherford, E., Stevens, K., Chen, D., Scherzer, R., Estrella, M., Sullivan, M. , Ebert, N., Mark, P. and Shlipak, M. (2022) FC077: Cystatin C testing improves risk stratification associated with chronic kidney disease without adopting age-adapted diagnostic thresholds : a UK Biobank Study. Nephrology Dialysis Transplantation, 37(Sup 3), I842-I843. (doi: 10.1093/ndt/gfac114.001)

Sullivan, M. , Mark, P. , Mair, F. , Jani, B. , Nitsch, D. and Lees, J. (2022) FC079: The Race-Free EGFR Equation, the kidney failure risk equation and referrals to specialist renal clinics. Nephrology Dialysis Transplantation, 37(Sup 3), i844-i845. (doi: 10.1093/ndt/gfac114.003)

Sullivan, M. K. and Mark, P. B. (2022) Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer? Cardiovascular Research, 118(8), e54-e56. (doi: 10.1093/cvr/cvac067) (PMID:35639861)

Sullivan, M. K. et al. (2022) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37(2), pp. 271-284. (doi: 10.1093/ndt/gfab303) (PMID:34661677) (PMCID:PMC8788218)

2021

Sullivan, M. K. et al. (2021) Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Medicine, 19, 278. (doi: 10.1186/s12916-021-02147-6)

Sullivan, M. K. et al. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14(11), pp. 2409-2419. (doi: 10.1093/ckj/sfab079) (PMCID:PMC8573008)

Lees, J. S. et al. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, 101030. (doi: 10.1016/j.eclinm.2021.101030) (PMID:34505030)

Drake, T. M. et al. (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet, 398(10296), pp. 223-237. (doi: 10.1016/S0140-6736(21)00799-6) (PMID:34274064) (PMCID:PMC8285118)

2020

McQueenie, R. et al. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15(8), e0238091. (doi: 10.1371/journal.pone.0238091) (PMID:32817712) (PMCID:PMC7440632)

Sullivan, M. , Rankin, A. , Jani, B. D. , Mair, F. S. and Mark, P. B. (2020) Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open, 10, e038401. (doi: 10.1136/bmjopen-2020-038401) (PMID:32606067) (PMCID:PMC7328898)

Articles

Walker, H., Sullivan, M. K. , Jani, B. D. , Mark, P. B. and Gallacher, K. I. (2024) Exploration of patients’ and health care professionals’ perspectives of kidney failure risk and the use of the kidney failure risk equation in MULTIPle lOng-term condItions aNd frailTy (MULTIPOINT) study: a qualitative interview and focus group study protocol. BMJ Open, 14(10), e085843. (doi: 10.1136/bmjopen-2024-085843) (PMID:39424379)

Walker, H., Day, S., Grant, C. H. , Jones, C., Ker, R., Sullivan, M. K. , Jani, B. D. , Gallacher, K. and Mark, P. B. (2024) Representation of multimorbidity and frailty in the development and validation of kidney failure prognostic prediction models: a systematic review. BMC Medicine, 22, 452. (doi: 10.1186/s12916-024-03649-9) (PMID:39394084) (PMCID:PMC11470573)

Elyan, B. M.P. , Sullivan, M. K. , Hedley, J., De La Mata, N., Webster, A. C., Venugopal, B., Jones, R. J. , Lang, N. N. , Mark, P. B. and Lees, J. S. (2024) The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis. BJC Reports, 2, 57. (doi: 10.1038/s44276-024-00081-7)

Sullivan, M. K. , Lees, J. S. , Rosales, B. M., Cutting, R., Wyld, M. L., Woodward, M., Webster, A. C., Mark, P. B. and De La Mata, N. (2024) Sex and the relationship between cardiometabolic risk factors and estimated GFR Decline: a population-based cohort study. American Journal of Kidney Diseases, (doi: 10.1053/j.ajkd.2024.05.007) (PMID:39053834) (In Press)

Shemilt, R. et al. (2024) Sex differences in cancer outcomes across the range of eGFR. Nephrology Dialysis Transplantation, (doi: 10.1093/ndt/gfae059) (PMID:38460949) (Early Online Publication)

Adamson, W. E. et al. (2024) Phenome-wide analysis reveals epistatic associations between APOL1 variants and chronic kidney disease and multiple other disorders. EBioMedicine, 101, 105000. (doi: 10.1016/j.ebiom.2024.105000) (PMID:38360481) (PMCID:PMC10944146)

Jani, B. D. , Sullivan, M. K. , Hanlon, P. , Nicholl, B. I. , Lees, J. S. , Brown, L., MacDonald, S. , Mark, P. B. , Mair, F. S. and Sullivan, F. M. (2023) Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role? British Journal of Cancer, (doi: 10.1038/s41416-023-02467-9) (PMID:37880510) (Early Online Publication)

Lees, J. S. , De La Mata, N. L., Sullivan, M. K. , Wyld, M. L., Rosales, B. M., Cutting, R., Hedley, J. A., Rutherford, E., Mark, P. B. and Webster, A. C. (2023) Sex differences in associations between creatinine and cystatin C-based kidney function measures with stroke and major bleeding. European Stroke Journal, 8(3), pp. 756-768. (doi: 10.1177/23969873231173282)

Shemilt, R. et al. (2023) Sex differences in the diagnosis of advanced cancer and subsequent outcome in people with chronic kidney disease: an analysis of a national population cohort. medRxiv, (doi: 10.1101/2023.08.22.23294412)

Mayne, K. J., Sullivan, M. K. and Lees, J. S. (2023) Sex and gender differences in the management of chronic kidney disease and hypertension. Journal of Human Hypertension, (doi: 10.1038/s41371-023-00843-9) (Early Online Publication)

Sullivan, M. K. et al. (2023) Potential impact of NICE guidelines on referrals from primary care to nephrology: a primary care database and prospective research study. British Journal of General Practice, 73(727), e141-e147. (doi: 10.3399/BJGP.2022.0145) (PMID:36376072) (PMCID:PMC9678375)

Sullivan, M. K. et al. (2022) The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function. BMC Medicine, 20, 420. (doi: 10.1186/s12916-022-02628-2) (PMID:36320059) (PMCID:PMC9623942)

Lees, J. S. , Rutherford, E., Stevens, K. I., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M. K. , Ebert, N., Mark, P. B. and Shlipak, M. G. (2022) Assessment of Cystatin C level for risk stratification in adults with chronic kidney disease. JAMA Network Open, 5(10), e2238300. (doi: 10.1001/jamanetworkopen.2022.38300) (PMID:36282503) (PMCID:PMC9597396)

Lees, J. , Rutherford, E., Stevens, K., Chen, D., Scherzer, R., Estrella, M., Sullivan, M. , Ebert, N., Mark, P. and Shlipak, M. (2022) FC077: Cystatin C testing improves risk stratification associated with chronic kidney disease without adopting age-adapted diagnostic thresholds : a UK Biobank Study. Nephrology Dialysis Transplantation, 37(Sup 3), I842-I843. (doi: 10.1093/ndt/gfac114.001)

Sullivan, M. , Mark, P. , Mair, F. , Jani, B. , Nitsch, D. and Lees, J. (2022) FC079: The Race-Free EGFR Equation, the kidney failure risk equation and referrals to specialist renal clinics. Nephrology Dialysis Transplantation, 37(Sup 3), i844-i845. (doi: 10.1093/ndt/gfac114.003)

Sullivan, M. K. and Mark, P. B. (2022) Daprodustat in renal anaemia: changing the response to cellular hypoxia, but is it a game changer? Cardiovascular Research, 118(8), e54-e56. (doi: 10.1093/cvr/cvac067) (PMID:35639861)

Sullivan, M. K. et al. (2022) Acute kidney injury in patients hospitalised with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study. Nephrology Dialysis Transplantation, 37(2), pp. 271-284. (doi: 10.1093/ndt/gfab303) (PMID:34661677) (PMCID:PMC8788218)

Sullivan, M. K. et al. (2021) Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings. BMC Medicine, 19, 278. (doi: 10.1186/s12916-021-02147-6)

Sullivan, M. K. et al. (2021) Multimorbidity and the risk of major adverse kidney events: findings from the UK Biobank cohort. Clinical Kidney Journal, 14(11), pp. 2409-2419. (doi: 10.1093/ckj/sfab079) (PMCID:PMC8573008)

Lees, J. S. et al. (2021) Kidney function and cancer risk: an analysis using creatinine and cystatin C in a cohort study. EClinicalMedicine, 38, 101030. (doi: 10.1016/j.eclinm.2021.101030) (PMID:34505030)

Drake, T. M. et al. (2021) Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study. Lancet, 398(10296), pp. 223-237. (doi: 10.1016/S0140-6736(21)00799-6) (PMID:34274064) (PMCID:PMC8285118)

McQueenie, R. et al. (2020) Multimorbidity, polypharmacy, and COVID-19 infection within the UK Biobank cohort. PLoS ONE, 15(8), e0238091. (doi: 10.1371/journal.pone.0238091) (PMID:32817712) (PMCID:PMC7440632)

Sullivan, M. , Rankin, A. , Jani, B. D. , Mair, F. S. and Mark, P. B. (2020) Associations between multimorbidity and adverse clinical outcomes in patients with chronic kidney disease: a systematic review and meta-analysis. BMJ Open, 10, e038401. (doi: 10.1136/bmjopen-2020-038401) (PMID:32606067) (PMCID:PMC7328898)